Skip Navigation


Carcinogenesis Advance Access originally published online on May 20, 2004
Carcinogenesis 2004 25(10):1945-1952; doi:10.1093/carcin/bgh184
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
25/10/1945    most recent
bgh184v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cheong, E.
Right arrow Articles by Johnson, I.T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheong, E.
Right arrow Articles by Johnson, I.T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis vol.25 no.10 © Oxford University Press 2004; all rights reserved.

ARTICLE

Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest

E. Cheong1,2, K. Ivory2, J. Doleman2, M.L. Parker2, M. Rhodes1 and I.T. Johnson2,3

1 General Surgery Department, Norfolk and Norwich University Hospital, Colney, Norwich NR4 7UY, UK and 2 Nutrition and Gastrointestinal Health Programme, Institute of Food Research, Norwich Research Park, Colney, Norwich NR4 7UA, UK

3 To whom correspondence should be addressed. Tel: +44 1603 255330; Fax: +44 (0) 1603 255167; Email: ian.johnson{at}bbsrc.ac.uk

Epidemiological studies suggest that the use of NSAIDs and/or a high intake of fruit and vegetables reduce the risk of oesophageal adenocarcinoma. Since COX-2 is up-regulated in Barrett's oesophageal carcinogenesis, the protective effect of NSAIDs and natural food components might reflect COX-2 inhibition. We explored the effects of quercetin, a natural flavonoid with a potent COX-2 inhibitory activity, and two commercially available selective COX-2 inhibitors (NS-398 and nimesulide) on cell proliferation, apoptosis, PGE2 production and COX-2 mRNA expression in a human oesophageal adenocarcinoma cell line (OE33). Changes in the relative numbers of adherent and floating cells were quantified and apoptotic cells were identified using ethidium bromide and acridine orange staining under fluorescence microscopy. Flow cytometric analysis of adherent and floating cells was used to quantify apoptosis and to examine the effects of the agents on the cell cycle. After 48 h exposure at concentrations of ≥1 µM both COX-2 inhibitors and quercetin suppressed cell proliferation (P < 0.01) and increased the fraction of floating apoptotic cells. At higher concentrations (50 µM) and longer exposure (48 h) the effects of quercetin were significantly greater than those of the selective COX-2 inhibitors (P < 0.01). Cell cycle analyses showed that quercetin blocked cells in S phase, while the selective COX-2 inhibitors blocked cells in G1/S interphase. COX-2 mRNA expression was suppressed by quercetin and the synthetic COX-2 inhibitors in a time- and dose-dependent manner. Quercetin and the synthetic COX-2 inhibitors (10 µM) suppressed PGE2 production by ~70% after 24 h exposure (P < 0.001). We conclude that OE33 is a useful model for the study of COX-2 expression and associated phenomena in human adenocarcinoma cells. Synthetic COX-2 inhibitors and the food-borne flavonoid quercetin suppress proliferation, induce apoptosis and cell cycle block in human oesophageal adenocarcinoma cells in vitro, and future studies should assess their effects in vivo.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
C.-J. Yen, J. G. Izzo, D.-F. Lee, S. Guha, Y. Wei, T.-T. Wu, C.-T. Chen, H.-P. Kuo, J.-M. Hsu, H.-L. Sun, et al.
Bile Acid Exposure Up-regulates Tuberous Sclerosis Complex 1/Mammalian Target of Rapamycin Pathway in Barrett's-Associated Esophageal Adenocarcinoma
Cancer Res., April 15, 2008; 68(8): 2632 - 2640.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
O. Ogunwobi, G. Mutungi, and I. L. P. Beales
Leptin Stimulates Proliferation and Inhibits Apoptosis in Barrett's Esophageal Adenocarcinoma Cells by Cyclooxygenase-2-Dependent, Prostaglandin-E2-Mediated Transactivation of the Epidermal Growth Factor Receptor and c-Jun NH2-Terminal Kinase Activation
Endocrinology, September 1, 2006; 147(9): 4505 - 4516.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J.-H. Yang, T.-C. Hsia, H.-M. Kuo, P.-D. L. Chao, C.-C. Chou, Y.-H. Wei, and J.-G. Chung
INHIBITION OF LUNG CANCER CELL GROWTH BY QUERCETIN GLUCURONIDES VIA G2/M ARREST AND INDUCTION OF APOPTOSIS
Drug Metab. Dispos., February 1, 2006; 34(2): 296 - 304.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.